Martin Lange
Corporate Officer/Principal en NOVO NORDISK A/S .
Cargos activos de Martin Lange
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2018 | - |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Director/Miembro de la Junta | 18/08/2023 | - |
Historial de carrera de Martin Lange
Antiguos cargos conocidos de Martin Lange.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/01/2017 | 20/02/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Director/Miembro de la Junta | 01/01/2006 | 01/01/2008 |
Formación de Martin Lange.
| University of Copenhagen | Doctorate Degree |
Estadísticas
Internacional
| Dinamarca | 4 |
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Empresas privadas | 3 |
|---|---|
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Martin Lange
- Experiencia
